Search Results - "Oba, Yuji"

The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review by Oba, Yuji, Abu-Salah, Tareq

“…Eosinophilic pleural effusion (EPE) is defined by an eosinophil count of ≥10% in the pleural fluid and often caused by air or blood in the pleural space. The…”
Get more information

Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis by Oba, Yuji, Lone, Nazir A

“…Roflumilast, a phosphodiesterase 4 inhibitor, has been shown to improve lung function and reduce exacerbation rates, but is associated with adverse events…”
Get full text

Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression by Oba, Yuji, Lone, Nazir A

“…We hypothesized a class effect of currently available long-acting muscarinic antagonists (LAMAs; i.e., tiotropium as a dry powder inhaler or a soft mist…”
Get full text

Mortality benefit of vasopressor and inotropic agents in septic shock: A Bayesian network meta-analysis of randomized controlled trials by Oba, Yuji, MD, FCCP, Lone, Nazir A., MD, MPH

“…Abstract Objective The choice of vasopressor in septic shock has been a matter of debate. The purpose of this study was to systematically review overall…”
Get full text

High levels of PEEP may improve survival in acute respiratory distress syndrome: A meta-analysis by Oba, Yuji, Thameem, Danish M, Zaza, Tareq

“…Summary Objective Positive end-expiratory pressure (PEEP) has been viewed as an essential component of mechanical ventilation in acute respiratory distress…”
Get full text

A case of acute non-typeable Hemophilus influenza infective endocarditis in a patient with hypocomplementemia by Patel, Parth, Fogwe, Delvis, Patel, Tarang, Patil, Sachin, Bran-Acevedo, Andres, Oba, Yuji, Roland, William

“…Hemophilus influenzae is a gram-negative bacteria responsible for significant cases of invasive infections, especially in the pediatric population and in…”
Get full text

Cost-Effectiveness of Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease by Oba, Yuji, MD

“…OBJECTIVE To evaluate and compare the cost-effectiveness of long-acting bronchodilators by estimating incremental costs per quality-adjusted life-year (QALY)…”
Get full text

Data Collection Issues With Mortality Risk of Inhaled Corticosteroids in COPD by Oba, Yuji

Get full text

Cardiovascular Safety of Roflumilast by Oba, Yuji, MD, Lone, Nazir A., MD

Get full text

Use of Esophageal Pressure Monitoring (EPM) in Morbidly Obese Patients on Mechanical Ventilation by Chandran, Arul, MD, Whitt, Stevan, MD, Whitacre, Troy, RRT, Oba, Yuji, MD, Johnson, Eric, PA, Devasahayam, Joe, MBBS, Omar, Fahad, MD

Get full text

Abandoning daily routine chest radiography in the intensive care unit: meta-analysis by Oba, Yuji, Zaza, Tareq

“…To systematically examine whether abandoning daily routine chest radiography would adversely affect outcomes, such as mortality and length of stay (LOS), and…”
Get full text

Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis by Oba, Yuji, Keeney, Edna, Ghatehorde, Namratta, Dias, Sofia

“…Long-acting bronchodilators such as long-acting β-agonist (LABA), long-acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations…”
Get more information

Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis by Oba, Yuji, Sarva, Siva T, Dias, Sofia

“…The place of long-acting β agonist/long-acting muscarinic antagonist (LABA/LAMA) combinations in stable patients with COPD is not well defined. The purpose of…”
Get more information

Phosphodiesterase inhibitors in chronic obstructive pulmonary disease by Oba, Yuji

Get full text

Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis by Oba, Yuji, Anwer, Sumayya, Maduke, Tinashe, Patel, Tarang, Dias, Sofia

“…Current guidelines recommend a higher-dose inhaled corticosteroids (ICS) or adding a long-acting muscarinic antagonist (LAMA) when asthma is not controlled…”
Get more information

Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis by Oba, Yuji, Anwer, Sumayya, Patel, Tarang, Maduke, Tinashe, Dias, Sofia

“…Inhaled corticosteroids (ICS) are the mainstay treatment for persistent asthma. Escalating treatment is required when asthma is not controlled with ICS therapy…”
Get more information

GASTROPLEURAL FISTULA: AN UNCOMMON ETIOLOGY OF VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM EMPYEMA by PATIL, SACHIN, CHEN, CLIFF, PATEL, TARANG, WINTERTON, BLAINE, OBA, YUJI

Get full text

“Ubi Pus, Ibi Evacua.” A Case of Complex Pleuroparenchymal Disease and Late Onset Empyema After Severe ARDS and Prolonged Mechanical Ventilation by Lone, Nazir, MD, Oba, Yuji, MD, Whitacret, Troy, RRT, Parker, William, DO, Sangha, Harbaksh, MD, Wang, Ying, MD, Hofmann, Hunter, MD

Get full text

Reply to On the need for competent evaluation of trial quality by Oba, Yuji

“…There are three parties that can be blinded in a randomized controlled trial (RCT), namely patients, treating physicians and outcome assessors. [...]blinded…”
Get full text

Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD by Oba, Yuji

“…To assess the incremental cost-effectiveness of inhaled medication use in chronic obstructive pulmonary disease (COPD). A Markov model was constructed to…”
Get full text